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Abstract: Personalized medicine is a model of healthcare that is predictive, personalized, 
preventive and participatory (“P4 Medicine”). Genetic counselors are an ideal group to 
study when designing tools to support cancer P4 Medicine activities more broadly. The 
goal for this work was to gain a better understanding of the information cancer genetic 
counselors seek from their patients to facilitate effective information exchange for 
discussing risk. This was an analysis of a qualitative data set from interviews of eight 
cancer genetic counselors, recruited from three institutions. Genetic counselors at each site 
were interviewed using a semi-structured, open-ended questionnaire. A selective coding 
approach was used to determine major themes associated with genetic counseling 
information needs for communicating risk. We generated a model for understanding 
categories of genetic counseling information needs to support risk communication activities. 
Common activities for risk communication included risk assessment and tailoring 
communication. Categories of information needs included: (a) clinical patient 
characteristics, (b) social and cognitive patient characteristics and (c) patient motivation 
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and goals for the genetic counseling session. A logical next step is for this model to inform 
the design of software systems for pre-visit patient planning and delivering just-in-time 
educational information to facilitate cancer risk communication activities. 




Personalized medicine may be defined broadly as a model of healthcare that is predictive, 
personalized, preventive and participatory (“P4 Medicine”). [1] The use of genomics data for P4 
Medicine is becoming more frequent, given the growing availability and decreasing costs of testing. 
Involving primary care physicians in delivering genetic services may be appropriate, given that the 
workforce of genetics professionals is limited in size. Primary care physicians generally have a 
favorable opinion of using cancer genetic data in their practice [2–4]; however, they do not feel 
adequately informed [5–7]. Effective genetic counseling makes complex genetic information 
understandable and personally relevant to the patients in terms of values, beliefs and lifestyle. Genetic 
counselors are among the few healthcare providers who are formally trained to deliver such complex 
genetic information and are, thus, an ideal group to study when designing tools to support counseling 
activities more broadly. 
The body of literature investigating information exchange with patients from the perspective of 
genetic counselors is modest. Moreover, studies that do exist focus primarily on what and how information 
is conveyed to the patient and the influence on patient understanding [8,9]. This study, however, is 
concerned with genetic counselor information needs, so counselors can more effectively convey 
information to their patients. For example, previous work indicates that if a healthcare provider is able 
to address the patients’ main concerns when they give bad news about cancer, and the patient perceives 
information to be relevant to their situation, then consultation is more likely to be beneficial [10]. 
Information exchange is also described as the first two steps in shared decision making among 
patients and healthcare providers [11]; that is (1) both the patient and the provider are involved and (2) 
both parties share information. A 2012 review of key concepts relevant to shared decision-making 
demonstrates that much of this literature focuses on the direct needs of patients [12]. This further 
illustrates a need for more studies that investigate genetic counselor information needs.  
Such knowledge of information needs will be important for designing usable technologies. Needs 
assessments are commonly conducted to identify user needs that inform software system design and 
establish system components [13]. With the future goal of designing software systems to facilitate 
cancer P4 Medicine practices more broadly, we conducted a needs assessment study with experienced 
cancer genetic counselors. A subsequent study is in progress to understand how the information 










This was a secondary data analysis of a previously collected qualitative data set from interviews of 
eight cancer genetic counselors recruited from Columbia University (New York, NY, USA), Huntsman 
Cancer Institute (Salt Lake City, UT, USA) and Fox Chase Cancer Center (Philadelphia, PA, USA). 
Informed consent was obtained for all participants, and each institution’s Institutional Review Board 
approved the study protocol. Data collection occurred over 3.5 months (late November through early 
March) in the year, 2010. The data were pooled and analyzed at Columbia University (protocol:  
IRB-AAAD6374). 
2.2. The Interview 
Cancer genetic counselors at each site were interviewed using a semi-structured, open-ended 
questionnaire. This interview included fifteen questions concerning communication processes (see 
Appendix 1). A team of a medical geneticist, a programmer and an informatics researcher developed 
questions. They were structured to gather data on the providers’ professional perception of risk 
communication, tailoring patient variables and patient communication procedures. The original goal 
was to use these data to identify common approaches to tailor risk communications and to determine 
differences in communication processes between genetic counselors and sites to inform the design of a 
tool for genetic counselors to support these processes. In this secondary analysis, our focus is narrowed 
to understanding the specific information cancer genetic counselors seek from their patients to support 
communication activities. Our ultimate goal is to inform the design of a tool that supports the exchange 
of information between patients and non-genetic counselor healthcare providers participating in cancer 
P4 Medicine activities.  
Each genetic counselor was interviewed once by telephone by one graduate-level research assistant. 
The duration of each interview was approximately 60 min. Audio recordings of each interview were 
assigned identification numbers and transcribed. We developed a codebook that initially included 
general themes extrapolated from the different categories of information elicited within the interview. 
Two graduate-level research assistants double-coded the transcripts. As new themes emerged, they 
were included in the codebook and assigned appropriately. Meetings were held bi-weekly to discuss 
discrepant coding among the research team. The NVivo 8 qualitative software program (QSR 
International; Doncaster, Australia) was used to maintain an electronic database of the consensus 
analysis of transcripts and information about each code. A final comparison of coding across all 
interviews yielded 67.75%–87.77% agreement. 
A “selective coding” approach [14] was utilized to determine major themes associated with genetic 
counselor information needs for common activities (e.g., tailoring communication for the patient). The 
themes were confirmed for accuracy using member checking with one participant who was removed 
from the data set. 
  





3.1. Sample Characteristics 
The demographics of the eight cancer genetic counselors interviewed are reported in Table 1.  
Table 1. Cancer genetic counselor demographics. 
Characteristics Genetic counselors (N = 8) N (%) 
Gender  
Female 8 (100.0) 
Male 0 
Geographic location  
New York, NY 2 (25.0) 
Salt Lake City, Utah 3 (37.5) 
Philadelphia, PA 3 (37.5) 
Education  
Master’s degree (M.S.), genetic 
counseling 
8 (100.0) 
3.2. Summary of Findings 
Results indicated that participants engaged in genetic counseling exhibit three dimensions of 
information needs to support common activity categories. As shown in Figure 1, provider information 
needs include: (a) patient goals and motivation for the genetic counseling session, (b) social and 
cognitive patient characteristics and (c) clinical patient characteristics.  






Social & cognitive patient 
characteristics
•  Perceptions of risk
•  Concerns
•  Personal values (e.g, sexuality, body 
image, personal life) 







•  Family history
•  Personal history (e.g., of cancer)
•  Personal risk factors
Information Need
Patient goals & motivations
Motivations
•  Personal experiences (e.g., with 
cancer, life changing events)
Goals
•  Make treatment decisions
•  Take preventive measures
•  Understand personal risk
•  Understand risk of family members




The common activity categories were: (a) performing an assessment of risk, (b) tailoring 
communication for the patient and (c) risk communication with the patient. Member checking later 
revealed that these activities are related to one another. We therefore refined our model to reflect this 
relationship. Specifically, after performing an assessment of risk, tailoring occurs during risk 
communication with the patient. Thus, risk assessment and tailoring communication were considered 
common activities supporting risk communication. Common risk assessment activities discussed by 
the cancer genetic counselors in this study included assessing risk (e.g., risk for primary cancer, risk 
for recurrent cancer, risk of carrying a BRCA1/BRCA2 mutation) and determining risk reduction with 
specific interventions (e.g., cancer surveillance, medication, surgery, radiation, lifestyle changes). 
Tailoring communication activities discussed by the genetic counselors included addressing patient 
concerns, assessing how the patient perceives risk, assessing how the patient understands numerical 
data, assessing anticipated reactions to possible options for action and communicating possible actions 
(e.g., cancer screening, cancer risk reduction, treatment, genetic testing).  
3.2.1. Theme 1: Clinical Patient Characteristics 
Cancer genetic counselors indicated that clinical patient characteristics (family history, personal 
history of cancer and personal risk factors) are important for risk assessment. Examples in which 
interviewees describe their process for collecting such data are as follows: 
“We send out what we call our health history questionnaire, and that‟s many, many 
questions on your health and things that you‟ve been exposed to. Now, it‟s extremely 
comprehensive, because we‟ve put together all of our risk assessment programs, so it has 
to do with tobacco exposure and alcohol exposure and a lot of different medication 
exposures, radiation exposures […]” Subject 3 
“On the medical history questionnaire, we ask about cancer diagnosis, as well as personal 
screening, when they started getting mammograms, if they‟ve had breast MRIs in the past, 
how many breast biopsies they‟ve had, enough information for us to do a Gail Model Risk 
if they haven‟t had breast cancer themselves. …Then, with the family history questionnaire, 
if they return that ahead of time, our schedulers put that into Progeny, so we already have 
a full pedigree drawn out when we go into the session and we‟re just kind of asking for 
updates or any changes if they learned more information about family members in the 
meantime.” Subject 4 
These quotes also illustrate that relevant data may be collected prior to coming into the clinic. Risk 
assessment commonly involves use of risk assessment tools to assess risk for breast cancer (e.g., the Gail 
model [15]) or for carrying a genetic mutation (e.g., BRCAPro [16]). Several interviewees described  
this process: 
“So, we basically have most of the family history information when the patient comes in to 
see us; so based on that information, we can use various different models that we have to 
assess the likelihood that somebody may actually carry a mutation in either BRCA 1 or 2.” 
Subject 7 




“We will get family history information, and we can plug that into Progeny and BRCAPro. 
So, we can get those kinds of [risk assessment] numbers before somebody actually walks in 
the door.” Subject 8 
After performing risk assessments, genetic counselors present risk information accounting for 
patient social and cognitive patient characteristics. 
3.2.2. Theme 2: Social and Cognitive Patient Characteristics 
Understanding social and cognitive patient characteristics was a recurrent theme among cancer 
genetic counselors discussing risk communication activities. To better tailor communication, cancer 
genetic counselors commonly ask questions to elicit from their patients personal values, such as issues 
of sexuality (e.g., how do they feel about their breasts in terms of their femininity and sexuality?) and 
where they are in their life stage (e.g., do they want to have children in the next five years?). These 
questions help providers to assess patient priorities and concerns, which can influence how they tailor 
a counseling session to an individual. One study participant, for example, described two patients she 
counseled a week earlier who were both newly diagnosed with breast cancer. One patient was advised 
to have a mastectomy and decided to have genetic testing first to refine her risk for a new breast cancer 
diagnosis, in the hopes that the risk was low to justify not having a mastectomy. The other patient was 
advised to have a lumpectomy and radiation and decided to have a bilateral mastectomy to ensure that 
she would never have another breast cancer diagnosis. 
“[…] for one, it was her body image, and to the other one, it was her fear of getting a new 
breast cancer. So, even though numerically the risk of getting a new breast cancer for both 
was probably 25%, the way they put that together was totally different.” Subject 3 
For a patient who already believes she is at high risk, it may be important to tailor communications 
to emphasize what is currently known about their risk and what a genetic test result can and cannot add 
to refining their risk. An interviewee describes how they tailor communication of treatment options 
given a patient has a highly penetrant mutation that increases their risk for breast cancer:  
“I try and get a sense from them if they‟ve thought ahead of time, you know, if they did 
come back positive, what management would they be comfortable with. Would they go 
more towards screening or would they go more towards surgery. And for all the patients, 
regardless of what their response is, I do present surgery as an option, but I definitely 
emphasize in all cases that it‟s an option and that it‟s not a strict recommendation to get it. 
If they are very much saying they wouldn‟t consider surgery, I wouldn‟t go into as many 
details about different surgical options or different cosmetic outcomes or whatnot.” 
Subject 4  
Cancer genetic counselors also want to understand the patients’ perceptions of risk and how the 
patient understands numerical data in order to tailor risk discussions. In response to the question: 
“What factors do you think may lead to misunderstanding about risk and how do you address these 
factors?” one interviewee describes this process as follows:  




“I think it‟s important to figure out what the patient initially perceives their risk to be. 
Whether they indicate that numerically or, you know, with words like high or low - so, you 
know where they‟re coming from [and] so that you can present your risk information in the 
appropriate context. I think that‟s figuring out how they‟re perceiving things. If they‟re 
overestimating, underestimating, maybe estimating correctly, but not necessarily assigning 
the right numerical value to, it helps you know what you need to present to them to 
hopefully get them to a point of more accurate understanding.” Subject 6  
In addition to assessing how the patient understands risk, cancer genetic counselors also want to 
know how the patient understands numerical data. Different ways to describe risk (e.g., percentage risk 
vs. category of risk) may be interpreted by patients in different ways. In response to the question: 
“How do you verbally tailor the information you give the patient? Do you phrase or state risk in a 
specific way?” one interviewee says: 
“[If] I‟m getting the sense that they‟re not as savvy [with numbers] as some of the patients, 
I really try to make it less number-based and just try to help them understand the overall 
concept that, you know, something increases versus decreases risks. Then, I have some 
patients that are just really savvy and have really great questions, and then, I‟ll get into 
much more detail with them. So, I‟ll kind of let the patient give me the cues to help me 
tailor.” Subject 5  
It is common for genetic counselors to deal with variation in how patients perceive risk by 
describing information in several different ways. For example, one interviewee said: 
“I think people need to hear the information in several different ways, so increased risks, 
you know, decreased risks, no risk or population risk of breast cancer, that can mean very 
different things to people.” Subject 2 
If a genetic counselor is able to clearly characterize how the patient understands risk and numerical 
data, however, it may better facilitate tailoring risk discussions. For example, one interviewee 
describes how she communicated risk using descriptive terms, rather than absolute numerical risk: 
“I had a patient last week that said „I don‟t think numbers mean anything to me. Numbers 
can lie, they don‟t mean anything.‟ So, for that person, I really tried to tailor that session 
to not be just about let‟s look at this bar graph and let‟s talk about risk, but let‟s talk about 
what you think […], in genetic counseling we‟re told to avoid being subjective, like [using] 
subjective terms, like low, medium and high. But, for somebody who can‟t really grasp or 
doesn‟t like numbers, you have to really categorize these risks for them.” Subject 9  
After presenting risk information to the patient, genetic counselors tailor options for testing and 
intervention. Social and cognitive patient characteristics may be important to consider when tailoring 
these options. One interviewee, for example, describes their encounter with one patient for whom body 
image was an important factor when considering risk reduction interventions: 
“[…] I had a patient tell me that she‟s had cancer and there‟s no way that she‟s ever going 
to be cut, period, and she told me how she was in labor for three days, and they wanted to 
do a C-section and there was no way she was going to let them give her any kind of scar on 




her body. So, from there, I learned how important her body image was to her. [After 
hearing that] I‟m really not going to spend that much time talking about risk reducing 
surgeries, such as prophylactic mastectomy. […] We could focus on something else.” 
Subject 9  
Although social and cognitive patient characteristics are important for tailoring options for testing 
and intervention, these decisions are made primarily based on patient goals and motivations. 
3.2.3. Theme 3: Patient Goals and Motivations for the Genetic Counseling Session 
Cancer genetic counselors indicated that it was common for them to start counseling sessions with 
questions, like “What brought you here today?” “What are you hoping to learn?” “What do you want 
to get out of this session?” and “What are your experiences with cancer?” to elicit patient motivations 
and goals for genetic counseling sessions. Understanding patient motivations and goals was a recurrent 
theme in our participants’ responses to questions about risk communication activities.  
Eliciting patient motivations and goals is important for cancer genetic counselors to tailor options. 
Concerns may be in regard to risk of primary cancer, risk of recurrence or risk of second primary (e.g., 
ovarian cancer after breast cancer). Other concerns may be about children or other family members’ 
risk of getting cancer. The following quote illustrates the variability in the motivations and goals of 
patients that should be considered in risk communications: 
“[…] my patients come in for several different reasons. I‟ll see patients who are newly 
diagnosed with cancer, and they‟re trying to make treatment decisions, so they want to 
know how likely it is that their cancer is hereditary and how aggressive they should be in 
their treatment decisions. That‟s one avenue of patients. I have another avenue of patients 
who have never been diagnosed with cancer, but have a strong family history of cancer, 
and they want to find out how likely it is that the cancers in their family are hereditary 
cancers. And, what they can do, what steps they can take to protect themselves against 
getting these cancers. And then, I have other people who come in because they‟ve been 
diagnosed with cancer in the past and are now ready to deal with whether or not the 
cancer is hereditary. And maybe, they want to provide helpful information for other family 
members or children, siblings.” Subject 3 
Tailoring the discussion to the risk of concern for the specific patient at that specific time is 
particularly important for determining appropriate treatment and prevention options for various 
scenarios. It was common, for example, for these interviewees to describe how patients’ personal 
experiences with breast cancer can lead to misunderstanding about risk. One interviewee describes 
how personal experiences with breast cancer influences perception of risk: 
“I don‟t think when people are thinking about their risk, they‟re thinking about them in 
numbers the way we are, so as geneticists, we‟re thinking about your risk as 15 percent 
versus 10 percent, but for the average woman, they might just be feeling like, „Yeah, my 
mom and sister got breast cancer; it‟s probably going to happen to me too.‟” Subject 6 




Further, many of our study participants suggested that understanding strategies for risk reduction is 
a common goal that is important for tailoring communication. Treatment decisions (mastectomy versus 
lumpectomy), for example, are often the immediate focus of discussion for patients with newly 
diagnosed breast cancer. 
It also appears to be important to understand patients’ personal experiences that influence their 
perceptions of risk. The following quote illustrates patient concerns about environmental effects, 
which should be addressed during discussions about risk. 
“[…] if they‟ve had a lot of neighbors that grew up getting cancer, they could be really 
worried about the environmental effects. And, some people do live in areas where there are 
certain higher incidences of cancer, but oftentimes, they can consider any cancer to be 
greatly inflated with that. Where, at least with some of the studies, more cancers can be 
prone to [environment] than others. And, some of the cancer in the family may not be 
related to the environmental effects as much or just be very difficult to prove. So, 
[someone] who may be a good genetic testing candidate may still be focused on the 
environmental effects.” Subject 4 
4. Discussion  
This study is a qualitative investigation of cancer genetic counselor information needs. Genetic 
counselors complete common information gathering activities, including: (a) clinical patient 
characteristics, (b) social and cognitive patient characteristics and (c) patient motivation and goals for 
the genetic counseling session. Based upon these data, they assess risk and tailor communication, 
which are important for discussing risk. We confirm risk communication activities and information 
needs identified in other studies. The main contribution of this study, however, is a conceptual model 
for how information is gathered from patients to support risk communication. This model can inform 
the design of technologies for pre-visit patient planning and delivering just-in-time educational 
information to support cancer risk communication activities. 
Risk communication activities are among commonly investigated genetic counseling processes [17]. 
In support of our findings, previous work indicates that counselees’ motivations for genetic counseling 
are often a topic of discussion [18]. Patients often have goals prior to a session [19] that could be 
incorporated into a consultation planning tool to help patients prepare for their counseling session and 
to help ensure that the session is tailored and most useful for the patient. A previous study suggests that 
insight into patient pre-visit needs may help counselors to better address patients’ concerns [20]. Following 
that study, however, investigators found that communications between counselors and counselees does 
not appear to reflect counselees’ pre-visit needs [18]. That finding further motivates exploring the 
development of tailoring technologies to facilitate the discussion of patient pre-visit needs, so that 
healthcare providers can respond more appropriately to patient-specific issues when counseling patients.  
Our conceptual model may inform the design of tailoring technologies delivered prior to a genetic 
counseling session. There are already examples in which use of consultation planning tools facilitate 
more client-specific counseling sessions [21] and improve patient satisfaction with counseling  
sessions [22,23]. These studies suggest that pre-visit patient planning can satisfy patient information 
needs and improve genetic counselor-patient communication. Our study provides evidence that genetic 




counselor information needs may also be satisfied prior to the counseling session. For example, we 
illustrated that clinical characteristics, such as family history and the patient’s medical history, can be 
gathered and risk calculated prior to the counseling session.  
Tailoring technologies may also be appropriate for delivering just-in-time educational information 
during “teachable moments” occurring within counseling sessions. Genetic counselors from this study, 
for example, indicate dealing with variation in how patients perceive risk by describing information in 
several different ways. Tailoring technologies may facilitate presenting numerical risk data in ways 
that account for such variation. Such technologies would be particularly useful for healthcare 
professionals who are not very familiar with genetics and are not formally trained to tailor risk 
discussions, but who are involved in the delivery of genetic services. 
Limitations and Implications for Future Research 
To inform the design of a system to support cancer risk communication activities, we were able to 
gather rich descriptive data associated with genetic counseling processes through interviewing. Our 
findings, however, may be limited by recall bias. To ensure that eight counselors were sufficient to 
reach saturation of our model, we completed additional steps to confirm themes for accuracy using 
member checking, and we discuss our findings in relation to observational studies that investigate 
genetic counselor communication processes. Like most qualitative studies, the generalizability of the 
findings is limited to the group studied. Even so, our goal was to understand the experiences of this 
particular group of participants so we can design software systems to support cancer P4 Medicine 
practices more broadly. 
The limitations of this study can serve to inform future studies. For example, the risk 
communication activities we identified are specific to cancer genetic counseling primarily testing for 
BRCA1/2 mutations known to increase risk for breast and ovarian cancer. The information needs we 
identified, however, may generalize to the perspectives of others who perform patient risk assessment 
activities for other diseases (e.g., cardiac or neurologic diseases) and based upon results from different 
tests (e.g., panel gene testing). Future studies should include multiple clinical specialties and tests in an 
effort to better understand the information needs that could be specific to disease areas and the ways in 
which test results are reported. 
This work also highlights a need to confirm under which contexts genetic counselor information 
needs occur. For example, while we found that cancer genetic counselors want to understand patients’ 
perceptions of risk in their discussions, we were unable to delineate at what point this information is 
most important. Previous work suggests that risk perception does not appear to be a major subject in initial 
visits, but deferred until risk can be better stratified based upon the results of genetic testing [18].  
In addition, of all of the studies identified in a 2008 review article, all but one assessed the initial 
consultation of clients [17]. This further indicates a need for more research on the exchange of 
information over time. 
5. Conclusions 
From this study, we have defined a conceptual model illustrating the dimensions of genetic 
counselor information needs and collecting specific types of information from patients during risk 




discussions. Types of information include (a) clinical patient characteristics, (b) social and cognitive 
patient characteristics and (c) patient motivation and goals for the genetic counseling session. Our 
model can inform the design of technologies for pre-visit patient planning and delivering just-in-time 
educational information to support cancer risk communication activities. 
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Appendix 1. Interview questions proposed to cancer genetic counselors. 
1. Do you consider a discussion about risk important when you counsel your patients? 
2. When you discuss patient’s risk, is it risk for gene mutation or risk for breast cancer? 
3. Are you comfortable in discussing risk? Probe answer. 
4. What factors do you think may lead to misunderstanding about risk and how do you  
address these factors? 
5. What are you most interested in learning about your patient so you can then do a better job tailoring 
your counseling session to their specific needs and characteristics? 
6. How do you assess patient’s characteristics in order to tailor the counseling session? 
7. Is there a pre counseling assessment (questionnaire)? Can you customize the questions that are on 
that assessment?  
8. How do you verbally tailor the information you give the patient? Do you phrase or state risk in a 
specific way?  
9. Would a computer-based educational resource be useful in communicating with a patient before, 
during or after the counseling session? Probe: for example, before to do the assessment of 
psychosocial, medical and clinical patient characteristics. 
10. What types of information, other than risk, would benefit a patient, or a counselor in communicating 
with a patient, in making a decision on genetic testing? 
11. Do you provide a patient with information prior to the patient entering the clinic? What type of 
information and in what format? 
12. What type of literature do you give the patient when she/he enters the clinic? Do you send any 
information to the patient after the counseling session (example: a summary letter)? 
13. When does a patient decide to go ahead with the genetic test? Do the patients need to make a 
decision before or after they leave the clinic? 
14. What is the amount of time scheduled for a counseling session with a patient? What is the amount of 
time given for patient questions/follow-up discussion? 
15. Can a patient bring one (or more) companion(s) to the counseling session? Does the presence of 
other people affect the manner in which a counselor counsels a patient? 
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